JPWO2020176527A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020176527A5 JPWO2020176527A5 JP2021549801A JP2021549801A JPWO2020176527A5 JP WO2020176527 A5 JPWO2020176527 A5 JP WO2020176527A5 JP 2021549801 A JP2021549801 A JP 2021549801A JP 2021549801 A JP2021549801 A JP 2021549801A JP WO2020176527 A5 JPWO2020176527 A5 JP WO2020176527A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- pharmaceutically acceptable
- acceptable salt
- compound
- hydrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962811456P | 2019-02-27 | 2019-02-27 | |
| US62/811,456 | 2019-02-27 | ||
| PCT/US2020/019724 WO2020176527A1 (en) | 2019-02-27 | 2020-02-25 | Triterpenoid antifungals for the treatment or prevention of pneumocystis spp. pneumonia |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022523212A JP2022523212A (ja) | 2022-04-21 |
| JP2022523212A5 JP2022523212A5 (https=) | 2023-02-24 |
| JPWO2020176527A5 true JPWO2020176527A5 (https=) | 2023-02-24 |
| JP7581219B2 JP7581219B2 (ja) | 2024-11-12 |
Family
ID=70005768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021549801A Active JP7581219B2 (ja) | 2019-02-27 | 2020-02-25 | ニューモシスチス属種（Ｐｎｅｕｍｏｃｙｓｔｉｓ ｓｐｐ．）肺炎を治療又は予防するためのトリテルペノイド系抗真菌薬 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US12594266B2 (https=) |
| EP (1) | EP3930716B1 (https=) |
| JP (1) | JP7581219B2 (https=) |
| KR (1) | KR20210133241A (https=) |
| CN (1) | CN113631165A (https=) |
| AU (1) | AU2020228036B2 (https=) |
| BR (1) | BR112021016876A2 (https=) |
| CA (1) | CA3131298A1 (https=) |
| EA (1) | EA202192344A1 (https=) |
| ES (1) | ES3055272T3 (https=) |
| IL (1) | IL285839A (https=) |
| MA (1) | MA55081A (https=) |
| MX (2) | MX2021010311A (https=) |
| TW (1) | TWI910099B (https=) |
| WO (1) | WO2020176527A1 (https=) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5166135A (en) * | 1988-09-12 | 1992-11-24 | Merck & Company, Inc. | Method for the control of pneumocystis carinii |
| DK173802B1 (da) * | 1988-09-12 | 2001-11-05 | Merck & Co Inc | Præparat til behandling af Pneumocystis carinii infeksioner og anvendelse af et cyclohexapeptid til fremstilling af et lægemiddel mod Pneumocystis carinii infektioner |
| US5756472A (en) | 1996-01-31 | 1998-05-26 | Merck & Co., Inc. | Antifungal agent obtained from hormonema |
| JP5245057B2 (ja) | 2006-04-03 | 2013-07-24 | メルク・シャープ・アンド・ドーム・コーポレーション | 抗真菌剤 |
| WO2010019204A1 (en) | 2008-08-12 | 2010-02-18 | Merck Sharp & Dohme Corp. | Antifungal agents |
| CN108883152A (zh) * | 2016-01-08 | 2018-11-23 | 奇达拉治疗公司 | 防止和治疗肺孢子虫感染的方法 |
| MA49889A (fr) * | 2017-04-10 | 2020-06-24 | Scynexis Inc | Agents antifongiques utilisés en association |
| KR102807716B1 (ko) * | 2017-08-04 | 2025-05-13 | 싸이넥시스, 인크. | 산성 pH에서 증진된 활성을 갖는 항진균제 |
-
2020
- 2020-02-25 BR BR112021016876A patent/BR112021016876A2/pt unknown
- 2020-02-25 JP JP2021549801A patent/JP7581219B2/ja active Active
- 2020-02-25 AU AU2020228036A patent/AU2020228036B2/en active Active
- 2020-02-25 WO PCT/US2020/019724 patent/WO2020176527A1/en not_active Ceased
- 2020-02-25 US US17/432,926 patent/US12594266B2/en active Active
- 2020-02-25 CA CA3131298A patent/CA3131298A1/en active Pending
- 2020-02-25 KR KR1020217030157A patent/KR20210133241A/ko active Pending
- 2020-02-25 MX MX2021010311A patent/MX2021010311A/es unknown
- 2020-02-25 EA EA202192344A patent/EA202192344A1/ru unknown
- 2020-02-25 EP EP20714386.8A patent/EP3930716B1/en active Active
- 2020-02-25 ES ES20714386T patent/ES3055272T3/es active Active
- 2020-02-25 CN CN202080023125.XA patent/CN113631165A/zh active Pending
- 2020-02-25 MA MA055081A patent/MA55081A/fr unknown
- 2020-02-27 TW TW109106501A patent/TWI910099B/zh active
-
2021
- 2021-08-24 IL IL285839A patent/IL285839A/en unknown
- 2021-08-26 MX MX2025004197A patent/MX2025004197A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2023027198A5 (https=) | ||
| TWI428131B (zh) | 使用升壓素拮抗劑以減少因接受蒽環類抗生素化療劑治療造成之心血管毒性和／或改善存活率之方法 | |
| US7919483B2 (en) | Method for the treatment of acne | |
| US20110046190A1 (en) | Combinations comprising a selective cyclooxygenase-2 inhibitor | |
| US20080161369A1 (en) | Epothilone derivative for the treatment of hepatoma and other cancer diseases | |
| JP5643213B2 (ja) | 肥大性心筋症治療用のホスホジエステラーゼタイプＩＩＩ（ＰＤＥＩＩＩ）インヒビターまたはＣａ２＋感作剤 | |
| JP2023030113A5 (https=) | ||
| JP2010065060A (ja) | 心不全処置のための複合治療 | |
| EP1689382A1 (de) | Pharmazeutische zusammensetzung aus einem beta-3-adrenozeptor-agonisten und einem in den prostaglandinstoffwechsel eingreifendem wirkstoff | |
| JP2020529999A5 (https=) | ||
| JP2020513037A5 (https=) | ||
| JPWO2020176527A5 (https=) | ||
| JP4608093B2 (ja) | 組合せ製剤としてのエンドセリン拮抗剤およびβ−受容体ブロッカー | |
| JP2020529999A (ja) | 酸性ｐＨで活性の増強を示す抗真菌剤 | |
| JPWO2021207335A5 (https=) | ||
| TWI532723B (zh) | 二苯基甲基哌衍生物及使用該衍生物之醫藥組成物 | |
| JPWO2020160316A5 (https=) | ||
| JPWO2020232037A5 (https=) | ||
| JPWO2020037152A5 (https=) | ||
| US20130142869A1 (en) | Compositions Comprising Non Steroidal Anti-inflammatory Drugs and Methods for Use Thereof | |
| JP2021508728A5 (https=) | ||
| US20230030113A1 (en) | Method of treating hypertension | |
| CN101287469A (zh) | 5－(2－氯苯基)－1,2－二氢－7－氟－8－甲氧基－3－甲基－吡唑并[3,4－b][1,4]苯并二氮杂䓬的给药方案 | |
| JP7581219B2 (ja) | ニューモシスチス属種（Ｐｎｅｕｍｏｃｙｓｔｉｓ ｓｐｐ．）肺炎を治療又は予防するためのトリテルペノイド系抗真菌薬 | |
| JPWO2023018904A5 (https=) |